Good or not good: Role of miR-18a in cancer biology

Tomasz Kolenda(Poznan University of Medical Sciences), Kacper Guglas(Medical University of Warsaw), Magda Kopczyńska(Poznan University of Medical Sciences), Joanna Sobocińska(Poznan University of Medical Sciences), Anna Teresiak(Greater Poland Cancer Center), Renata Bliźniak(Greater Poland Cancer Center), Katarzyna Lamperska(Greater Poland Cancer Center)
Reports of Practical Oncology & Radiotherapy
August 12, 2020
Cited by 92Open Access
Full Text

Abstract

miR-18a is a member of primary transcript called miR-17-92a (C13orf25 or MIR17HG) which also contains five other miRNAs: miR-17, miR-19a, miR-20a, miR-19b and miR-92a. This cluster as a whole shows specific characteristics, where miR-18a seems to be unique. In contrast to the other members, the expression of miR-18a is additionally controlled and probably functions as its own internal controller of the cluster. miR-18a regulates many genes involved in proliferation, cell cycle, apoptosis, response to different kinds of stress, autophagy and differentiation. The disturbances of miR-18a expression are observed in cancer as well as in different diseases or pathological states. The miR-17-92a cluster is commonly described as oncogenic and it is known as 'oncomiR-1', but this statement is a simplification because miR-18a can act both as an oncogene and a suppressor. In this review we summarize the current knowledge about miR-18a focusing on its regulation, role in cancer biology and utility as a potential biomarker.


Related Papers

No related papers found

Powered by citation graph analysis